Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W.
Christopher W DaviesSimon E VidalLilian PhuJawahar SudhamsuTrent B HinkleScott Chan RosenbergFrances-Rose SchumacherYi Jimmy ZengCarsten SchwerdtfegerAndrew S PetersonJennie R LillChristopher M RoseAndrey S ShawIngrid E WertzDonald S KirkpatrickJames T KoerberPublished in: Nature communications (2021)
The ubiquitin conjugating enzyme UBE2W catalyzes non-canonical ubiquitination on the N-termini of proteins, although its substrate repertoire remains unclear. To identify endogenous N-terminally-ubiquitinated substrates, we discover four monoclonal antibodies that selectively recognize tryptic peptides with an N-terminal diglycine remnant, corresponding to sites of N-terminal ubiquitination. Importantly, these antibodies do not recognize isopeptide-linked diglycine (ubiquitin) modifications on lysine. We solve the structure of one such antibody bound to a Gly-Gly-Met peptide to reveal the molecular basis for its selective recognition. We use these antibodies in conjunction with mass spectrometry proteomics to map N-terminal ubiquitination sites on endogenous substrates of UBE2W. These substrates include UCHL1 and UCHL5, where N-terminal ubiquitination distinctly alters deubiquitinase (DUB) activity. This work describes an antibody toolkit for enrichment and global profiling of endogenous N-terminal ubiquitination sites, while revealing functionally relevant substrates of UBE2W.